106 Impact of discontinuing hypertonic saline and dornase alfa in people with cystic fibrosis established on elexacaftor-tezacaftor-ivacaftor: A SIMPLIFY ancillary study
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: N. Hamblett, A. Gifford, M. Kloster, R. Russell, A. Braun, R. Gibson, J. Hoppe, R. Jain, R. Linnemann, T. Liou, J. Lysinger, C. Milla, J. Young, D. Nichols Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research